SCHEMBL7879710

SCHEMBL7879710

CN(C(=N)N)C(=O)c1cc2c(Cl)cc(Oc3ccc(CN4CCCC4)s3)cc2[nH]1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.31
DRD3 P35462 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
HRH4 Q9H3N8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7879493 0.88 SCN9A (0.33) HRH3
SCHEMBL7884361 0.87 RHEB (0.33)
SCHEMBL7879822 0.86 RHEB (0.32)
SCHEMBL7943749 0.86 FLT3 (0.39) DRD2DRD3HRH3HRH4
SCHEMBL7879668 0.85 HRH3 (0.39) DRD2DRD3HRH3
SCHEMBL7877811 0.85 HRH3 (0.41) HRH3
SCHEMBL7879503 0.84 HRH3 (0.32) HRH3
SCHEMBL7879825 0.84 KDM4E (0.33) DRD2DRD3HRH4
SCHEMBL7880065 0.84 RHEB (0.31)
SCHEMBL7884245 0.83 FAAH (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed